Adenovirus (oncolytic agent from DNAtrix)

oncolytic adenovirus · DNAtrix, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Adenovirus (oncolytic agent from DNAtrix), covering 2021-07-15 to 2021-07-15. Get the full timeline:

Most recent: Clinical Trial Update: Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects [Phase 2]